Skip to main content
Fig. 3 | Malaria Journal

Fig. 3

From: Monitoring changes in malaria epidemiology and effectiveness of interventions in Ethiopia and Uganda: Beyond Garki Project baseline survey

Fig. 3

Age-specific seroprevalence for P. falciparum anti-MSP-119 antibodies. Dots, continuous lines and broken lines represent data, fitted estimates and 95 % confidence intervals, respectively. λ is the seroconversion rate. The 0–2 years age group was omitted because of distortions caused by presence of maternal antibody in high endemicity settings [35]

Back to article page